| Log in
Photo Credit: Social Media

Exclusive: Symbiotec Pharmalab gets interest from new set of PE firms

12 June, 2017

Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis Advisers Pvt. Ltd looks to sell its stake in the make ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Actis elicits interest from investors for stake in Symbiotec Pharmalab

Actis elicits interest from investors for stake in Symbiotec Pharmalab

Ranjani R 1 year ago
Private equity firm Actis Capital, which invested in Symbiotec Pharmalab in...
Exclusive: Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

Exclusive: Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

Ranjani R 7 months ago
Private equity (PE) firm Actis Advisers Pvt. Ltd. has engaged an investment bank...
Actis invests $48M in drug manufacturer Symbiotec Pharmalab

Actis invests $48M in drug manufacturer Symbiotec Pharmalab

TEAM VCC 4 years ago
Private equity firm Actis has invested $48 million (around Rs 295 crore) to pick...
No Comments

Exclusive: Symbiotec Pharmalab gets interest from new set of PE firms

Powered by WordPress.com VIP